A Phase 2 clinical trial will evaluate the safety and efficacy of potential new therapeutics for COVID-19, including an investigational therapeutic based on synthetic monoclonal antibodies (mAbs) to treat the disease. Researchers sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, are working with clinical sites
EU health officials foresee a “moderate to high” risk of more new coronavirus clusters of the type happening in northern Italy, they said in a statement after a meeting Monday. The warning, by the bloc’s Health Security Committee, echoed one by the World Health Organization which said countries around the planet should prepare for a
Medicare’s randomized trial of a new bundled payment model for hip and knee replacement surgeries led to $812 in savings per procedure, or a 3.1% reduction in costs, when compared with traditional means of paying for care, according to new research from Harvard T.H. Chan School of Public Health and Harvard Medical School. The study
Prostate cancer is the commonest form of cancer in the Western world. Between 15 to 20 percent of men are affected by it at some time in their lives and 2.6 percent die from prostate cancer. That equates to 1,000 deaths a year in Austria. Apart from genetic factors, environmental (epigenetic) risk factors also play
Moderate to severe mid-life anxiety may be linked to dementia in later life, suggests an analysis of the available published evidence in the online journal BMJ Open. But as yet, it’s not clear whether active treatment could curb this risk, and whether non-drug therapies, such as mindfulness and meditation, which are known to reduce anxiety
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok